1. 1. Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin, 73(1): 17-48. [DOI:10.3322/caac.21763]

2. Park S, Oh D, Choi YL, et al. (2022) Durvalumab and tremelimumab with definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma. Cancer, 128(11):2148-2158. [DOI:10.1002/cncr.34176]

3. Shah MA, Bennouna J, Doi T, Shen L, et al. (2021) KEYNOTE-975 study design: a phase III study of definitive chemoradiotherapy plus pembrolizumab in patients with esophageal carcinoma. Future Oncol, 17(10): 1143-1153. [DOI:10.2217/fon-2020-0969]

4. Cinicola J, Mamidanna S, Yegya-Raman N, et al. (2023) A review of advances in radiotherapy in the setting of esophageal cancers. Surg Oncol Clin N Am, 32(3): 433-459. [DOI:10.1016/j.soc.2023.03.004]

5. Hridya VT, Khanna D, Aswathi R, et al. (2023) A study to evaluate optimal plan through different photon. Int J Radiat Res, 21(2): 337-342.

6. Lee SL, Mahler P, Olson S, et al. (2021) Reduction of cardiac dose using respiratory-gated MR-linac plans for gastro-esophageal junction cancer. Med Dosim, 46(2): 152-156. [DOI:10.1016/j.meddos.2020.10.002]

7. Vošmik M, Hodek M, Buka D, et al. (2020) Cardiotoxicity of radiation therapy in esophageal cancer. Reports of Practical Oncology & Radiotherapy, 25(3): 318-22. [DOI:10.1016/j.rpor.2020.02.005]

8. Boekhoff MR, Defize IL, Borggreve AS, et al. (2021) CTV-to-PTV margin assessment for esophageal cancer radiotherapy based on an accumulated dose analysis. Radiother Oncol, 161:16-22. [DOI:10.1016/j.radonc.2021.05.005]

9. Voncken FEM, Nakhaee S, Stam B, et al. (2020) Quantification of esophageal tumor motion and investigation of different image-guided correction strategies. Pract Radiat Oncol, 10(2): 84-92. [DOI:10.1016/j.prro.2019.11.012]

10. Hoffmann L, Poulsen PR, Ravkilde T, et al. (2019) Setup strategies and uncertainties in esophageal radiotherapy based on detailed intra-and interfractional tumor motion mapping. Radiother Oncol, 136:161-168. [DOI:10.1016/j.radonc.2019.04.014]

11. Monadi N, Shahbazi-Gahrouei D, et al. (2023) Dosimetric characteristics of tomotherapy and three dimensional conformal radiotherapy for head and neck. Int J Radiat Res, 21(3):427-434. [DOI:10.61186/ijrr.21.3.427]

12. Watcharawipha A, Chitapanarux I, Jia-Mahasap B (2022) Dosimetric comparison of large field widths in helical tomotherapy for intracranial stereotactic radiosurgery. Int J Radiat Res, 20(3):701-707.

13. Kirli-Bolukbas M and Karaca S (2020) Effect of lung volume on helical radiotherapy in esophageal cancer: are there predictive factors to achieve acceptable lung doses? Strahlenther Onkol, 196(9): 805-812. [DOI:10.1007/s00066-020-01581-4]

14. Guo MF, Zhao XJ, Huang Y, et al. (2022) The dosimetric and clinical comparison between helical tomotherapy and fixed-field intensity-modulated radiotherapy in radical irradiation for cervical cancer. Int J Radiat Res, 20(2):377-382. [DOI:10.52547/ijrr.20.2.18]

15. Wang Y, Xiao Q, Zeng B, et al. (2020) Tomotherapy as a neoadjuvant treatment for locally advanced esophageal cancer might increase bone marrow toxicity in comparison with intensity-modulated radiotherapy and volumetric-modulated arc therapy. Med Dosim, 45(1): e6-e12. [DOI:10.1016/j.meddos.2019.05.001]

16. Gu Q, Lai XJ, Yang SY, et al. (2017) Dosimetric comparison between helical tomotherapy and intensity-modulated radiotherapy for esophageal carcinoma. Precision Radiation Oncology, 1(3):88-93. [DOI:10.1002/pro6.21]

17. Gay HA and Niemierko A (2007) A free program for calculating EUD-based NTCP and TCP in external beam radiotherapy. Phys Med, 23(3-4): 115-125. [DOI:10.1016/j.ejmp.2007.07.001]

18. Kastelowitz N, Marsh MD, McCarter M, et al. (2021) Impact of radiation dose on postoperative complications in esophageal and gastroesophageal junction cancers. Front Oncol, 11. [DOI:10.3389/fonc.2021.614640]

19. Takeuchi Y, Murakami Y, Kameoka T, et al. (2020) Analysis of cardiac toxicity after definitive chemoradiotherapy for esophageal cancer using a biological dose-volume histogram. J Radiat Res, 61(2):298-306. [DOI:10.1093/jrr/rraa001]

20. Yakar M, Etiz D, Metintas M, et al. (2021) Prediction of radiation pneumonitis with machine learning in stage III lung cancer: A pilot study. Technol. Cancer Res Treat, 20:1-10. [DOI:10.1177/15330338211016373]

21. Mijiti M, Li D, Yan R, et al. (2023) Development of nomogram for predicting major complications in patients with esophageal cancer in the early postoperative period. BMC Surg, 23(1):186. [DOI:10.1186/s12893-023-02090-8]

22. Katsuta T, Murakami Y, Kawahara D, et al. (2023) Novel simulation for dosimetry impact of diaphragm respiratory motion in four-dimensional volumetric modulated arc therapy for esophageal cancer. Radiother Oncol, 187. [DOI:10.1016/j.radonc.2023.109849]

23. Münch S, Oechsner M, Combs SE, Habermehl D (2017) DVH- and NTCP-based dosimetric comparison of different longitudinal margins for VMAT-IMRT of esophageal cancer. Radiat Oncol, 12:128. [DOI:10.1186/s13014-017-0871-3]

24. Tang W, Li X, Yu H, et al. (2021) A novel nomogram containing acute radiation esophagitis predicting radiation pneumonitis in thoracic cancer receiving radiotherapy. BMC Cancer, 21(1):585. [DOI:10.1186/s12885-021-08264-y]

25. Inoo H, Sakanaka K, Fujii K, et al. (2022) Association of volumetric-modulated arc therapy with radiation pneumonitis in thoracic esophageal cancer. Int J Radiat Res, 63(4):646-656. [DOI:10.1093/jrr/rrac021]

26. Tonison JJ, Fischer SG, Viehrig M, et al. (2019) Radiation pneumonitis after intensity-modulated radiotherapy for esophageal cancer: Institutional data and a systematic review. Sci Rep, 9(1): 2255. [DOI:10.1038/s41598-018-38414-5]

27. Luna JM, Chao H-H, Diffenderfer ES, et al. (2019) Predicting radiation pneumonitis in locally advanced stage II-III non-small cell lung cancer using machine learning. Radiother Oncol, 133:106-112. [DOI:10.1016/j.radonc.2019.01.003]

28. Boekhoff MR, Lagendijk JJW, van Lier ALHMW, et al. (2023) Intrafraction motion analysis in online adaptive radiotherapy for esophageal cancer. Phys Imag Radiat Onc, 26. [DOI:10.1016/j.phro.2023.100432]

29. Frandsen J, Boothe D, Gaffney DK, et al. (2015) Increased risk of death due to heart disease after radiotherapy for esophageal cancer. J Gastrointest Oncol, 6(5):516-523.

30. Tao Y, Lu J, Deng W, et al. (2023) Correlation of mean heart dose and cardiac biomarkers with electrocardiographic changes in patients receiving thoracic radiation therapy. Radiat Res, 199(4): 336-345. [DOI:10.1667/RADE-22-00135.1]

31. Goldoost B, Goldoost N, Esnaashari O, Mostafanezhad K (2019) Evaluating the effects of esophageal and breast cancer. Int J Radiat Res, 17(2):237-244.

32. Wang X, Palaskas NL, Yusuf SW, et al. (2020) Incidence and onset of severe cardiac events after radiotherapy for esophageal cancer. J Thorac Oncol, 15(10):1682-1690. [DOI:10.1016/j.jtho.2020.06.014]